Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA approves use of Cinryze to prevent angioedema attacks in pediatric patients with HAE

June 21, 2018

Immune Design opens phase III study of CMB-305 for synovial sarcoma

June 21, 2018

Atossa completes dosing in phase I study of topical endoxifen

June 21, 2018

New phase II trial studies arimoclomol for Gaucher's disease

June 21, 2018

Aquinnah Pharmaceuticals obtains NINDS grant to develop ALS drugs

June 21, 2018

Loss-of-function mutation in TCF12 gene linked to autosomal dominant Kallmann syndrome

June 21, 2018

GSX2 gene identified as causative of basal ganglia agenesis

June 21, 2018

Moxetumomab pasudotox pivotal trial data in relapsed/refractory hairy cell leukemia reported

June 21, 2018

Phase II dose of BAL-101553 defined in solid tumors trial

June 21, 2018

Missense mutations in GLIS1 gene are linked to malformation syndromes

June 21, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...